Answers are grounded in this paper and cite their sources.
Many participants played a role in discovering the composition and sequence of the Abeta amyloid of Alzheimer's disease. This sequence enabled the cloning of the amyloid precursor protein (APP), which elucidated its proteolytic origin from the membrane of neurons. The proteolytic enzymes which process APP and the Abeta fragment itself are now the prime validated drug targets for therapeutic intervention.
No takes yet. Share an insight, caveat, or question.
Masters et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: